PIMIVALIMAB

UNII:	MA05AF40UO
Formula:
Preferred Substance Name:	PIMIVALIMAB
GSRS Full Record:	MA05AF40UO i

2293951-22-9
IMMUNOGLOBULIN G4 (226-PROLINE,C-TERMINAL-LYSINE-CLIPPED), ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1) (HUMAN MONOCLONAL JTX-4014 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL JTX-4014 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS PROGRAMMED CELL DEATH 1 LIGAND 1 (PD-L1; CD274 ANTIGEN)); HUMAN MONOCLONAL ANTIBODY; .GAMMA.4 HEAVY CHAIN HOMO SAPIENS (1-444) (VH HOMO SAPIENS (IGHV1-46*01 (97%) (IGHD)-IGHJ5*02) (8.8.11) (1-118)-HOMO SAPIENS IGHG4*01 ((HINGE(S10>P(226)), CH3(K107>DEL(445))) (119-444)) (132-214')-DISULFIDE WITH .KAPPA. LIGHT CHAIN HOMO SAPIENS (1'-214') (V-KAPPA (HOMO SAPIENS IGKV1-5*01 (98%) IGKJ4*01)(6.3.9) (1'-107')-HOMO SAPIENS IGKC*01 (108'-214')), DIMER (224-224'':227-227'')-BISDISULFIDE, PRODUCED IN CHO CELL, GLYCOFORM ALFA
JTX-4014
PIMIVALIMAB [INN]
PIMIVALIMAB [USAN]
PIMIVALIMAB [WHO-DD]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

PIMIVALIMAB

Synonyms and Mappings

Resources